Actively Recruiting
Study of Immune Responses in Adults After Acute Stroke and Its Link to Cognitive Decline
Led by University of Oslo · Updated on 2022-03-14
40
Participants Needed
1
Research Sites
179 weeks
Total Duration
AI-Summary
What this Trial Is About
Some patients experience cognitive decline after a stroke, but the reasons are not always clear. Researchers are studying whether an autoimmune response could explain this cognitive decline in a subgroup of stroke patients. This observational study aims to better understand immune system changes following a stroke. Participants in this study will have their immune responses analyzed through blood samples taken shortly after a stroke. The focus is on B cell and T cell activity in peripheral blood collected within one day of enrollment. The study does not involve treatment but observes natural immune responses after stroke. During the study, participants will provide blood samples to assess their immune response. Researchers will measure specific immune cells and monitor changes to understand the connection between stroke and cognitive decline. The study is led by the University of Oslo and will continue until June 2029.
CONDITIONS
Brief Title
The Immune Response to Stroke
Research Team
A
Andreas Lossius, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
